|
A Novel Non-Invasive CRC Test Based on Mass Spec Of In Vitro Expressed Proteins
|
5R44CA119565-03
|
$455,651
|
$455,651
|
Han, James
|
AMBERGEN, INC
|
|
Molecular Test for Inherited Mutations in Breast Cancer
|
5R44CA110403-04
|
$463,209
|
$463,209
|
Lim, Mark
|
AMBERGEN, INC
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
|
2U01CA098710-05
|
$1,063,219
|
$1,063,219
|
THUN, MICHAEL
|
AMERICAN CANCER SOCIETY, INC.
|
|
Novel Gene Networks in Breast Development and Cancer
|
5P01CA030195-26
|
$2,398,875
|
$383,820
|
Oesterreich, Steffi
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-02S1
|
$117,286
|
$3,519
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-02
|
$1,515,000
|
$45,450
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of AIB3 in Mammary Gland and Breast Cancer
|
5R01CA119689-04
|
$280,899
|
$280,899
|
XU, JIANMING
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Biology and Diagnosis of Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
|
5R01CA072851-13
|
$326,412
|
$326,412
|
BOLAND, Clement
|
BAYLOR RESEARCH INSTITUTE
|
|
Use of CCI-779 in multiple myeloma
|
1R21CA121464-01A2
|
$319,950
|
$79,988
|
LICHTENSTEIN, ALAN
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
Mitochondrial Haplogroups and Breast Cancer Risk
|
5R03CA130050-02
|
$87,500
|
$87,500
|
Cox, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
|
5P50CA105009-05
|
$2,176,201
|
$1,088,101
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Partners Southwestern Clinical Epidemiology/Validation
|
5U01CA086381-09
|
$926,029
|
$926,029
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
p53 signatures and pelvic serous carcinoma
|
5R21CA124688-02
|
$143,004
|
$71,502
|
Crum, Christopher
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Susceptibility to Endometrial Cancer
|
5R01CA082838-09
|
$325,450
|
$325,450
|
DEVIVO, Immaculata
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genome Wide Association Study: Variants Influencing Steroid Hormone Levels
|
5R03CA128034-02
|
$87,500
|
$87,500
|
devivo, Immaculata
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Telomere Length and Endometrial Cancer
|
5R03CA132190-02
|
$87,500
|
$43,750
|
DEVIVO, Immaculata
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Prospective Study of DNA Repair Gene Variants in Breast Cancer
|
5R01CA118447-02
|
$330,435
|
$330,435
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Variants in Immunological Mediator Genes and Skin Cancer Risk
|
5R03CA132175-02
|
$86,936
|
$43,468
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-09
|
$4,719,623
|
$283,177
|
HANKINSON, SUSAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Biochemical Markers in the nurses' Health Study Cohort
|
5R01CA049449-19
|
$1,213,763
|
$971,010
|
Hankinson, Susan
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cohort Study of Genetic Susceptibility to Breast Cancer
|
5R01CA065725-12
|
$408,468
|
$408,468
|
HUNTER, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
|
5U01CA098233-06
|
$1,555,544
|
$1,555,544
|
HUNTER, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Nitric Oxide Synthase Polymorphisms and Risk for Skin Cancer
|
5R03CA130055-02
|
$87,500
|
$87,500
|
QURESHI, ABRAR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Calmodulin in neoplastic transformation of breast tissue
|
5R01CA075205-09
|
$369,080
|
$184,540
|
SACKS, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Testing and Cancer Screening in Hereditary Cancer Syndromes
|
5K07CA120448-02
|
$141,548
|
$141,548
|
STOFFEL, ELENA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genomic and proteomic analysis of prostate cancer
|
5R01CA105304-05
|
$209,928
|
$209,928
|
SADAR, MARIANNE
|
BRITISH COLUMBIA CANCER AGENCY
|
|
Ontario Familial Breast Cancer Registry
|
5U01CA069467-14
|
$712,896
|
$712,896
|
ANDRULIS, IRENE
|
CANCER CARE ONTARIO
|
|
Web-based Family History Screening for Hereditary Breast Cancer Risk
|
5R21CA127837-02
|
$154,500
|
$154,500
|
ACHESON, LOUISE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-18S3
|
$234,254
|
$2,343
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-19S1
|
$72,416
|
$724
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-19S2
|
|
$0
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-19
|
$5,104,000
|
$51,040
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cancer Research Network Across Health Care Systems
|
5U19CA079689-10
|
$4,846,464
|
$969,293
|
WAGNER, EDWARD
|
CENTER FOR HEALTH STUDIES
|
|
Variation in Ara-C Pathway Genes and Treatment Outcomes in AML
|
5R21CA119142-02
|
$152,926
|
$152,926
|
GOYAL, RAKESH
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
|
Clinical Correlative Studies of Neuroblastoma
|
5R01CA060104-15
|
$411,318
|
$411,318
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Diagnostic and Prognostic Sarcoma Signatures
|
5U01CA114757-04
|
$1,689,820
|
$1,689,820
|
Triche, Timothy
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Genetics of pediatric rhabdoid tumors
|
2R01CA046274-17A2
|
$266,860
|
$266,860
|
BIEGEL, JACLYN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
1R01CA124709-01A2
|
$675,621
|
$675,621
|
MARIS, JOHN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Glycobiology of Human Medulloblastoma
|
3R01CA061010-13S1
|
$41,500
|
$41,500
|
LADISCH, STEPHAN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
2P30CA033572-25
|
$2,342,475
|
$70,274
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S1
|
$95,134
|
$2,854
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S2
|
$107,415
|
$3,222
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CpG Methylation and Mutation
|
5R01CA084469-09
|
$293,558
|
$293,558
|
Pfeifer, Gerd
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
DNA methylation in cancer genomes
|
5R21CA128495-02
|
$211,250
|
$211,250
|
Pfeifer, Gerd
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Genetics Career Development Program
|
5R25CA085771-08
|
$85,677
|
$4,284
|
WEITZEL, JEFFREY
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Molecular Basis for Spitzoid Tumors
|
1R03CA133925-01
|
$80,500
|
$80,500
|
CELEBI, JULIDE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
2P30CA013696-35
|
$3,785,244
|
$151,410
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
AIDS Associated Lymphoproliferative Disorders
|
5R37CA037295-25
|
$432,500
|
$432,500
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A pilot study of statin therapy and risk of malignant glioma
|
1K07CA127468-01A1
|
$135,513
|
$67,757
|
Lai, Rose
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Metropolitan New York Registry of Breast Cancer Families
|
5U01CA069398-15
|
$427,162
|
$427,162
|
TERRY, MARY BETH
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Total relevant funding to Genetic Testing for this search: $157,377,283
|